Don't let it get away!
Keep track of the stocks that matter to you.
Help yourself with the Fool's FREE and easy new watchlist service today.
Shares of biotech Agenus (Nasdaq: AGEN ) appreciated almost 5% today, after the company posted its 3rd quarter earnings. The company's key compound, QS-21 Stimulon, is licensed to some of the biggest players in the pharmaceutical space, ,including GlaxoSmithKline (NYSE: GSK ) and Janssen, which is a subsidiary of Johnson & Johnson (NYSE: JNJ ) .
In the following video, health care analysts Max Macaluso and David Williamson discuss the company's latest quarter and a few things Agenus investors should watch.
Biotech companies can be some of the most exciting-and riskiest-investments on the market. However, it's essential to balance speculative plays in your portfolio with stocks that can help you build long-term weatlh. In our free report "3 Stocks That Will Help You Retire Rich," we name stocks that could help you retire well, and also include some winning wealth-building strategies that every investor should know. Click here now to keep reading.
RSS Headlines
Comments from our Foolish Readers
Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the
Report this Comment icon found on every comment.
Be the first one to comment on this article.